Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002062847A3 Superficial zone protein and methods of making and using same
06/19/2003WO2002057315A3 Streptococcal streptolysin s vaccines
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2002026815A3 Identification of neuroblastoma tumor suppressor genes
06/19/2003WO2002010205A3 Mutations of the mdr1 p-glycoprotein that improve its ability to confer resistance to chemotherapeutic drugs
06/19/2003WO2002004664A3 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030115614 Complementarity region determination antibodies; culture product; antiinflammatory agents, autoimmune diseases, viricides, bactericides
06/19/2003US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114653 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030114652 Hybrid polypeptide; genetic engineering
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114379 Encoded protein for treating leukemia, leukocytes, and bone marrow stem cell colony formation
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030114354 Computer for producing a three-dimensional representation of a molecule or molecular complex
06/19/2003US20030113940 Antibodies specific for nanotubes and related methods and compositions
06/19/2003US20030113909 G protein coupled receptor protein, production and use thereof
06/19/2003US20030113896 Medical diagnosis; detection of antibodies
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113835 Methods for protein synthesis, protein screening and retrieval of protein function
06/19/2003US20030113820 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113818 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113808 Apolipoprotein biopolymer markers predictive of alzheimers disease
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113780 Antibodies to crosslinkers and methods for using the same
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113747 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113344 Induce an immunogenic response in animals to non-typable Haemophilus influenzae
06/19/2003US20030113343 Identification and characterization of novel pneumococcal choline binding protein, CbpG, and diagnostic and therapeutic uses thereof
06/19/2003US20030113339 Methods to improve immunogenicity of antigens and specificity of antibodies
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113334 Cytotoxic antibodies specifically bind to proteins which were expressed in lymphatic tumors
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113332 An isolated nucleic acid molecule codes a protein like CD2 antigen, transmembrane domains; genetic engineering, fusion cells, monoclonal antibodies use as antitumor agents
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113330 Administering an antagonist of the renin-angiotensin-aldosterone, inhibiting cell apoptosis; treating lung disorders
06/19/2003US20030113326 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth
06/19/2003US20030113325 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113322 CDR-H1-derived peptide CB11, pharmaceutical compositions made therefrom and methods of treating disorders in mammals
06/19/2003US20030113319 Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
06/19/2003US20030113318 TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
06/19/2003US20030113316 Stable lyophilized pharmaceutical formulation of IgG antibodies
06/19/2003CA2848193A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2469802A1 A structure for presenting desired peptide sequences
06/19/2003CA2469306A1 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003CA2469274A1 Tumor antigens
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2469045A1 Methods of therapy for non-hodgkin's lymphoma
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/19/2003CA2468753A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/18/2003EP1319950A1 Matrix screening method
06/18/2003EP1319715A1 IMP dehydrogenase and its use for the identification of fungicidal substances
06/18/2003EP1319669A2 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
06/18/2003EP1319186A1 Prognostic indicator
06/18/2003EP1319184A2 Use of antibodies against specific mhc-peptide complexes
06/18/2003EP1319089A1 In vitro assay for measuring the immunogenicity of a vaccine
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319072A2 G-protein coupled receptor hfrbn63
06/18/2003EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1254155A4 Mob-5/hmob-5 as a cancer diagnostic marker
06/18/2003EP1181306A4 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
06/18/2003EP1069827A4 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
06/18/2003EP0960338B1 Diagnostic methods and compositions based on the distribution of rad51
06/18/2003CN1425136A Assay of isomerised and/or optically inverted proteins and protein fragments
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425027A HCV non-structural polypeptide
06/18/2003CN1424327A Preparation and use of thymic peptide alpha-1 monocloned antibody
06/18/2003CN1424326A Monocloned antibody for eight plant viruses and inspection thereof
06/18/2003CN1111540C Tandem synthetic HIV-1 peptides
06/18/2003CN1111429C Urease-based vaccine against HeIicobacter infection
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 1494